Literature DB >> 12175546

Unique K-ras mutational pattern in pancreatic adenocarcinoma from Taiwanese patients.

Jaw Y Wang1, Shen T Lian, Yi F Chen, Yuan C Yang, Li T Chen, King T Lee, Tsung J Huang, Shiu R Lin.   

Abstract

To assess the prevalence and spectrum of K-ras mutations in Taiwanese patients with pancreatic adenocarcinoma, we analyzed 20 patients of ductal adenocarcinoma of the head of the pancreas undergoing pancreaticoduodenectomy. The study included K-ras mutations that were detected using DNA direct sequencing analysis of the polymerase chain reaction products and confirmed by reverse sequencing primers. The results showed that K-ras codon 12 mutation was detected in 90% of the cancer tissues (18/20). Moreover, the results from direct sequencing indicated that missense mutations were found to be a GGT to GTT in 94.5% of the cases (17/18) and a GGT to TTT in 5.5% of the cases (1/18). All cases with K-ras codon 12 mutations were found to be G to T transversion. However, no alterations were found at codons 13 and 61. From these findings, the high prevalence of K-ras codon 12 mutation in pancreatic adenocarcinoma and the predominant G to T transversion with the preferential substitution of glycine with valine might indicate an unusual sensitivity and specificity of this codon in genetic alterations for pancreatic carcinogenesis. The strikingly high mutational rate and the unique mutational spectrum of K-ras codon 12 in Taiwanese pancreatic adenocarcinoma can provide us with more information about the alternative diagnostic and therapeutic strategies in Taiwan.

Entities:  

Mesh:

Year:  2002        PMID: 12175546     DOI: 10.1016/s0304-3835(01)00818-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Missense mutations in MLH1, MSH2, KRAS, and APC genes in colorectal cancer patients in Malaysia.

Authors:  Nor Azian Abdul Murad; Zulhabri Othman; Melati Khalid; Zuraini Abdul Razak; Rosniza Hussain; Sukumar Nadesan; Ismail Sagap; Isa Mohamed Rose; Wan Zurinah Wan Ngah; Rahman Jamal
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

2.  Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.

Authors:  Brendan J Quinn; Matthew Dallos; Hiroshi Kitagawa; Ajaikumar B Kunnumakkara; Regan M Memmott; M Christine Hollander; Joell J Gills; Phillip A Dennis
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-14

3.  Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.

Authors:  S Rachagani; S Senapati; S Chakraborty; M P Ponnusamy; S Kumar; L M Smith; M Jain; S K Batra
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640

4.  Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe.

Authors:  Ji-Dung Luo; Err-Cheng Chan; Chun-Liang Shih; Tai-Long Chen; Ying Liang; Tsann-Long Hwang; Chiuan-Chian Chiou
Journal:  Nucleic Acids Res       Date:  2006-01-23       Impact factor: 16.971

Review 5.  Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.

Authors:  Divya Murthy; Kuldeep S Attri; Pankaj K Singh
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

6.  Detection of activated KRAS from cancer patient peripheral blood using a weighted enzymatic chip array.

Authors:  Ming-Yii Huang; Hsueh-Chiao Liu; Li-Chen Yen; Jia-Yuan Chang; Jian-Jhang Huang; Jaw-Yuan Wang; Chao-Peng Hsiao; Shiu-Ru Lin
Journal:  J Transl Med       Date:  2014-05-26       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.